LBLCF - Cannabis Weekly Round-Up: US Congress Adds Protection for Industry
During the past trading week (June 17 to 21), the US Congress voted in favor of an amendment to prevent the Justice Department from cracking down on the marijuana industry in the US using federal funds.
A new report on the potential value of the marijuana industry by 2024 made headlines, while the confirmation of tax revenue seen since the legalization of recreational products in Canada also caught attention.
Here’s a closer look at some of the biggest news during last week’s trading period.
US Congress Vote
The US marijuana industry gained a new layer of protection thanks to the passing of a measure to prevent any obstruction from the Department of Justice into legal cannabis programs at the state level.
The amendment approved by the US House of Representatives would be attached to the fiscal year 2020 Commerce-Justice-Science spending bill. Because of the policy, the federal agency would not be allowed to use any funds for the criminal pursuit of marijuana programs in medically and recreationally legal states.
According to a report from MJBiz Daily on Thursday (June 20), the vote was approved 267 to 165 against.
New projections on value of marijuana market
On Thursday, a new report from the Arcview Market Research and BDS Analytics indicated that, thanks to the growth seen industry-wide in 2018, the researchers now foresee a sales value of US$40 billion by 2024.
“A key takeaway from the report is that highly restrictive regulations and high tax rates are hurting the legal market’s ability to compete with the illicit market,” Tom Adams, managing director and principal analyst for BDS Analytics’ Industry Intelligence group, said in a press release. “But legalization advocates endorsed our view that all 50 US states can be expected to be medically legal by 2024, and that 20 will have adult-use sales.”
According to the report, the Canadian recreational cannabis market is expected to grow to US$4.8 million by 2024.
“Investment capital raised by cannabis companies more than quadrupled to US$14 billion in 2018, according to Viridian Capital Advisors,” the research firms indicated in a press release.
Canada reports taxes revenues and consumer trends
The Canadian statistics agency issued an update on the financial results the country has seen by way of taxes since the opening of the recreational market on October 17.
Statistics Canada reported that the government has collected a total of C$186 million on taxes from legal cannabis products sold since the launch of adult-use sales up to the end of March.
In 2019 alone, provincial governments have accumulated C$79 million in excise taxes, while the federal government secured C$19 million of tax revenue.
The government agency also issued a new report on the early trends from Canadian consumers, indicating a surprising increase in reported consumers during the first three months of 2019 in Ontario and Quebec. This study was conducted using self-reported data from Canadian consumers.
Market updates
Shoppers Drug Mart, a Loblaw Companies (TSX:L,OTC Pink:LBLCF) subsidiary, announced a new agreement on Monday to use a blockchain-based program to track medical cannabis sold through its online platform.
The deal is being done in collaboration with TruTrace Technologies (CSE:TTT,OTC Pink:BKKSF) to deploy the TruTrace’s StrainSecure technology. The Toronto-based company reached a listing on the Canadian Securities Exchange on June 14.
Ken Weisbrod, vice president of Shoppers Drug Mart, said it’s critical for medical cannabis consumers to know the source of their purchases so that both patients and practitioners can gain another level of certainty on the integrity of the product.
“When a patient takes medication, there is an expectation that it is standardized, and they can expect consistent clinical outcomes and results. Although that’s not always a guarantee within the medical cannabis industry at the moment, we’re hoping this new program can help change that,” the Shoppers executive said.
This past week, investors of multi-state operator (MSO) Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF) and Canopy Growth (NYSE:CGC,TSX:WEED) voted their approval on the proposed acquisition arrangement between the two firms, which is set to take place once marijuana becomes federally legal in the US.
“Alongside our international market strategies and US Hemp strategy, we believe the acquisition of Acreage will be a key step in bolstering our position as a truly global company,” Bruce Linton, co-CEO of Canopy Growth, said in a press release.
Shares of Canopy Growth dropped on Friday (June 21) after the company issued its Q4 and fiscal 2019 results, reporting a net loss of just over C$323.3 million for the quarter. The net loss per share for the firm during its Q4 was C$0.98 per share, while that of its full fiscal year was C$2.57 per share.
As of 12:30 p.m. EDT on Friday, shares of the Canadian cannabis producer took a hit both in New York, where it dropped 8.51 percent, and Toronto, with a decline of 8.18 percent.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Editorial Disclosure: Acreage Holdings and TruTrace Technologies are clients of the Investing News Network. This article is not paid-for content.
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.